Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102227401> ?p ?o ?g. }
- W2102227401 endingPage "233" @default.
- W2102227401 startingPage "224" @default.
- W2102227401 abstract "Background Whether lipoproteins are better markers than lipids and lipoproteins for coronary heart disease is widely debated. Our aim was to compare the apolipoproteins and cholesterol as indices for risk of acute myocardial infarction. Methods We did a large, standardised case-control study of acute myocardial infarction in 12 461 cases and 14 637 age-matched (plus or minus 5 years) and sex-matched controls in 52 countries. Non-fasting blood samples were available from 9345 cases and 12 120 controls. Concentrations of plasma lipids, lipoproteins, and apolipoproteins were measured, and cholesterol and apolipoprotein ratios were calculated. Odds ratios (OR) and 95% CI, and population-attributable risks (PARs) were calculated for each measure overall and for each ethnic group by comparison of the top four quintiles with the lowest quintile. Findings The apolipoprotein B100 (ApoB)/apolipoprotein A1 (ApoA1) ratio had the highest PAR (54%) and the highest OR with each 1 SD difference (1·59, 95% CI 1·53–1·64). The PAR for ratio of LDL cholesterol/HDL cholesterol was 37%. PAR for total cholesterol/HDL cholesterol was 32%, which was substantially lower than that of the ApoB/ApoA1 ratio (p<0·0001). These results were consistent in all ethnic groups, men and women, and for all ages. Interpretation The non-fasting ApoB/ApoA1 ratio was superior to any of the cholesterol ratios for estimation of the risk of acute myocardial infarction in all ethnic groups, in both sexes, and at all ages, and it should be introduced into worldwide clinical practice. Funding Canadian Institutes of Health Research, the Heart and Stroke Foundation of Ontario, the International Clinical Epidemiology Network (INCLEN). Unrestricted grants from pharmaceutical companies (with major contributions from AstraZeneca, Novartis, Aventis, Abbott, Bristol Myers Squibb, King Pharma, and Sanofi-Synthelabo), and by various national bodies." @default.
- W2102227401 created "2016-06-24" @default.
- W2102227401 creator A5014632361 @default.
- W2102227401 creator A5018419311 @default.
- W2102227401 creator A5021376482 @default.
- W2102227401 creator A5027641313 @default.
- W2102227401 creator A5037187866 @default.
- W2102227401 creator A5041524274 @default.
- W2102227401 creator A5047343682 @default.
- W2102227401 creator A5061519671 @default.
- W2102227401 creator A5075405688 @default.
- W2102227401 creator A5080292021 @default.
- W2102227401 creator A5081548605 @default.
- W2102227401 creator A5086791009 @default.
- W2102227401 date "2008-07-01" @default.
- W2102227401 modified "2023-10-16" @default.
- W2102227401 title "Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study" @default.
- W2102227401 cites W1982729232 @default.
- W2102227401 cites W1988933958 @default.
- W2102227401 cites W2007573188 @default.
- W2102227401 cites W2018715171 @default.
- W2102227401 cites W2028440739 @default.
- W2102227401 cites W2045054080 @default.
- W2102227401 cites W2087606026 @default.
- W2102227401 cites W2089103283 @default.
- W2102227401 cites W2097716578 @default.
- W2102227401 cites W2105103856 @default.
- W2102227401 cites W2106296033 @default.
- W2102227401 cites W2113886741 @default.
- W2102227401 cites W2130813021 @default.
- W2102227401 cites W2141659719 @default.
- W2102227401 cites W2143820284 @default.
- W2102227401 cites W2151722413 @default.
- W2102227401 cites W2154998675 @default.
- W2102227401 cites W2155121555 @default.
- W2102227401 cites W2160452475 @default.
- W2102227401 cites W2164576143 @default.
- W2102227401 cites W2328176404 @default.
- W2102227401 doi "https://doi.org/10.1016/s0140-6736(08)61076-4" @default.
- W2102227401 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18640459" @default.
- W2102227401 hasPublicationYear "2008" @default.
- W2102227401 type Work @default.
- W2102227401 sameAs 2102227401 @default.
- W2102227401 citedByCount "714" @default.
- W2102227401 countsByYear W21022274012012 @default.
- W2102227401 countsByYear W21022274012013 @default.
- W2102227401 countsByYear W21022274012014 @default.
- W2102227401 countsByYear W21022274012015 @default.
- W2102227401 countsByYear W21022274012016 @default.
- W2102227401 countsByYear W21022274012017 @default.
- W2102227401 countsByYear W21022274012018 @default.
- W2102227401 countsByYear W21022274012019 @default.
- W2102227401 countsByYear W21022274012020 @default.
- W2102227401 countsByYear W21022274012021 @default.
- W2102227401 countsByYear W21022274012022 @default.
- W2102227401 countsByYear W21022274012023 @default.
- W2102227401 crossrefType "journal-article" @default.
- W2102227401 hasAuthorship W2102227401A5014632361 @default.
- W2102227401 hasAuthorship W2102227401A5018419311 @default.
- W2102227401 hasAuthorship W2102227401A5021376482 @default.
- W2102227401 hasAuthorship W2102227401A5027641313 @default.
- W2102227401 hasAuthorship W2102227401A5037187866 @default.
- W2102227401 hasAuthorship W2102227401A5041524274 @default.
- W2102227401 hasAuthorship W2102227401A5047343682 @default.
- W2102227401 hasAuthorship W2102227401A5061519671 @default.
- W2102227401 hasAuthorship W2102227401A5075405688 @default.
- W2102227401 hasAuthorship W2102227401A5080292021 @default.
- W2102227401 hasAuthorship W2102227401A5081548605 @default.
- W2102227401 hasAuthorship W2102227401A5086791009 @default.
- W2102227401 hasConcept C126322002 @default.
- W2102227401 hasConcept C134018914 @default.
- W2102227401 hasConcept C139572402 @default.
- W2102227401 hasConcept C156957248 @default.
- W2102227401 hasConcept C164705383 @default.
- W2102227401 hasConcept C2778163477 @default.
- W2102227401 hasConcept C2780072125 @default.
- W2102227401 hasConcept C2780745583 @default.
- W2102227401 hasConcept C2908647359 @default.
- W2102227401 hasConcept C500558357 @default.
- W2102227401 hasConcept C62746215 @default.
- W2102227401 hasConcept C71924100 @default.
- W2102227401 hasConcept C99454951 @default.
- W2102227401 hasConceptScore W2102227401C126322002 @default.
- W2102227401 hasConceptScore W2102227401C134018914 @default.
- W2102227401 hasConceptScore W2102227401C139572402 @default.
- W2102227401 hasConceptScore W2102227401C156957248 @default.
- W2102227401 hasConceptScore W2102227401C164705383 @default.
- W2102227401 hasConceptScore W2102227401C2778163477 @default.
- W2102227401 hasConceptScore W2102227401C2780072125 @default.
- W2102227401 hasConceptScore W2102227401C2780745583 @default.
- W2102227401 hasConceptScore W2102227401C2908647359 @default.
- W2102227401 hasConceptScore W2102227401C500558357 @default.
- W2102227401 hasConceptScore W2102227401C62746215 @default.
- W2102227401 hasConceptScore W2102227401C71924100 @default.
- W2102227401 hasConceptScore W2102227401C99454951 @default.
- W2102227401 hasIssue "9634" @default.
- W2102227401 hasLocation W21022274011 @default.
- W2102227401 hasLocation W21022274012 @default.